Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis

Bone Marrow Transplant. 2023 Nov;58(11):1260-1263. doi: 10.1038/s41409-023-02034-z. Epub 2023 Aug 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Abatacept
  • Bone Marrow Transplantation
  • Child
  • Graft vs Host Disease* / prevention & control
  • Hematologic Neoplasms* / therapy
  • Hematopoietic Stem Cell Transplantation*
  • Histocompatibility Testing
  • Humans
  • Retrospective Studies
  • Unrelated Donors

Substances

  • Abatacept